Clinical trial
Disturbance of Water and Sodium Metabolism After Surgery of Sellar Lesions, and Correspond Clinical Strategy
NCT01406041 is registered in ClinicalTrials.gov with Southern Medical University, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Disturbance of Water and Sodium Metabolism After Surgery of Sellar Lesions, and Correspond Clinical Strategy
- Lead sponsor
- Southern Medical University, China
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 28, 2011
- Completion date
- May 12, 2021
- Enrollment
- 350 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
the fluid and electrolyte imbalance happened after surgery, the patients suffered with sellar diseases